Global Facial Injectables Market by Type, Application and Geography - Growth, Trends and Forecast Analysis, 2019 to 2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 10, 2019--The “Global Facial Injectables Market - Segmented by Type, Application, and Geography - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.
The facial injectables market is expected to register a CAGR of 12% over the forecast period.
Factors such as rising aesthetic consciousness, increasing number of cosmetic procedures, the demographic trend towards aging population, and the introduction of cost-effective facial injectables are contributing to the growth of the market. However, the side effects of the procedures, the presence of counterfeit products and unregistered practitioners, and unfavorable reimbursement policies could impede market growth.
Rising Aesthetic Consciousness and Number of Cosmetic Procedures
The cosmetic industry is booming, and it has undergone an estimated three-fold increase in turnover, over the past decades. In particular, there has been a surge in the total number of non-surgical therapies, such as injections of wrinkle relaxers and dermal fillers. This trend is primarily due to the advantages provided by technology, such as low recovery time, less risk of infection, no blood loss, and the overall reduction in procedural costs.
According to the American Society of Plastic Surgeons, the total number of procedures employing soft tissue fillers increased by approximately 312% during the last fifteen years, and in the same period, the utilization of wrinkle relaxers increased by a staggering 809%. During 2017, the number of nonsurgical procedures increased by 7%. During 2016, the total number of nonsurgical cosmetic procedures in the United States registered an increase of 7%. Among the nonsurgical cosmetic procedures, the most prominent addition was in hyaluronic acid fillers, which recorded a growth of 16%.
Other factors that are contributing to the growth of the market include a rapidly aging population and the introduction of cost-effective facial injectables.
Side-effects Associated with Available Products
Owing to recent advances in cosmetic techniques and the increasing presence of skilled personnel, facial injection procedures are being conducted with a high success rate. However, the side-effects associated with available injectable products remains a significant hindrance for the wider adoption of injectable techniques.
Some common side effects associated with dermal fillers and wrinkle relaxants include redness, swelling, drooping of the eyelid, hives, rashes, and itching. Most of the adverse effects of facial injectables are transient. However, there is a risk of more severe complications. For example, Botulism toxin could travel to the respiratory muscles and cause difficulty in swallowing and breathing. Skin cell death is also associated with the use of dermal fillers, which could lead to scarring and requirement of additional surgery.
Other factors which could potentially impede the market growth include the lack of reimbursement policies supporting cosmetic procedures and the presence of counterfeit products and unregistered practitioners.
North America Dominates the Facial Injectables Market
In 2017, North America was the largest regional market, in terms of revenue. The aging population, increasing demand for non-invasive aesthetic procedures, and the presence of a well-established cosmetic industry are the primary factors augmenting the large market size. The Asia-Pacific market is expected to grow at a rapid pace, over the forecast period, owing to increasing disposable income and the trend of medical tourism in the major markets of the region.
- Feb 2018: Allergan announced plans to acquire Elastagen. The acquisition is aimed at incorporating Elastagen’s clinical stage Tropoelastin platform into its facial injectables portfolio.
- Allergan PLC
- Anika Therapeutics Inc.
- Ipsen SA
- Medytox Inc
- Merz Pharma GmbH & Co KGaA
- Nestle Skin Health (Galderma Pharma SA)
- Sanofi SA
- Sinclair Pharma PLC
- Suneva Medical Inc.
- Teoxane SA
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
6. Market Dynamics
6.1 Facial Injectables Market Drivers
6.1.1 Rising Aesthetic Consciousness and Number of Cosmetic Procedures
6.1.2 Introduction of Cost-effective Facial Injectables
6.1.3 Ageing Population
6.2 Facial Injectables Market Restraints
6.2.1 Side-effects of Available Products
6.2.2 Lack of Reimbursement Policies Supporting Cosmetic Procedures
6.2.3 Presence of Counterfeit Products and Unregistered Practitioners
6.3 Facial Injectables Market Opportunities
6.4 Facial Injectables Market Key Challenges
7. Market Segmentation
7.1 Facial Injectables Market By Type
7.1.1 Wrinkle Relaxers
7.1.2 Dermal Fillers
22.214.171.124 Calcium hydroxylapatite
126.96.36.199 Fat injection
188.8.131.52 Hyaluronic acid
184.108.40.206 Polylactic acid
220.127.116.11 Polymethyl-methacrylate microspheres (PMMA)
18.104.22.168 Other Dermal Fillers (Polyalkylimide etc.)
7.2 Facial Injectables Market By Application
7.2.1 Facial Line Correction
7.2.2 Lip Augmentation
7.2.3 Face Lift
7.2.4 Acne Scar Treatment
7.2.5 Lipoatrophy treatment
7.2.6 Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)
7.3 Facial Injectables Market By Geography
7.3.1 North America
7.3.4 Middle East & Africa
7.3.5 South America
8. Facial Injectables Market Key Players and Competitive Landscape
8.1 Allergan PLC
8.2 Anika Therapeutics Inc.
8.3 Ipsen SA
8.4 Medytox Inc.
8.5 Merz Pharma GmbH & Co. KGaA
8.6 Nestl Skin Health (Galderma Pharma SA)
8.7 Sanofi SA
8.8 Sinclair Pharma PLC
8.9 Suneva Medical Inc.
8.10 Teoxane SA
*List Not Exhaustive
9. Future of the Facial Injectables Market
For more information about this report visit https://www.researchandmarkets.com/r/mgwi61
View source version on businesswire.com:https://www.businesswire.com/news/home/20190410005355/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infusions and Injectables
INDUSTRY KEYWORD: RETAIL OTHER RETAIL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 04/10/2019 04:16 AM/DISC: 04/10/2019 04:16 AM